Èric Massana

Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial

Bianca Maria Piraccini, Ulrike Blume‐Peytavi, F. Scarci et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 157 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)

Matthias Augustin, Rachel Sommer, E. Daudén et al. · BMJ Open · 2023 · 20 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +16

First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of abediterol (LAS100977), a novel long‐acting Β₂‐agonist

Wolfgang Timmer, Èric Massana, Eulalia Jiménez et al. · The Journal of Clinical Pharmacology · 2014 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma

Jutta Beier, Rainard Fuhr, Èric Massana et al. · Respiratory Medicine · 2014 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study

Dave Singh, Helena Pujol, Anna Ribera et al. · BMC Pulmonary Medicine · 2014 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17